Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets 
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO 
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends 
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban 
Visa to Move European Headquarters to London’s Canary Wharf 
 - EconoTimes)
NEW YORK, Dec. 02, 2015 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against ERBA Diagnostics, Inc. (“ERBA” or the “Company”) (NYSE:ERB) and certain of its present and former officers in the United District Court for the Southern District of Florida on behalf of a class consisting of all persons or entities who purchased ERBA securities between April 14, 2014 and November 23, 2015, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company lacked adequate controls over financial reporting; (ii) the Company’s financial statements during the Class Period were materially false and misleading; and (iii) as a result of the foregoing, Defendants’ statements regarding ERBA’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
On November 20, 2015, ERBA disclosed that the Company’s previously issued financial statements for each of the years ended December 31, 2014 and 2013 and for each of the interim periods ended March 31, 2015 and June 30, 2015 (collectively, the “Non-Reliance Periods”) should no longer be relied upon. ERBA further disclosed that it intends to restate its financial statements for the Non-Reliance Periods.
On this adverse news, ERBA’s shares fell $0.30, or over 17%, to close at $1.44 on November 23, 2015.
If you wish to serve as lead plaintiff, you must move the Court no later than February 1, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.
